Literature DB >> 16269967

Oxidative stress contributes to the enhanced expression of Gialpha proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats.

Georgios Lappas1, Grace Bou Daou, Madhu B Anand-Srivastava.   

Abstract

OBJECTIVE: We have previously shown an enhanced expression of Gialpha proteins in spontaneously hypertensive rats (SHR) that precedes the development of hypertension. Since oxidative stress has been shown to be increased in SHR, the present studies were undertaken to examine the role of oxidative stress in enhanced expression of Gialpha proteins in SHR.
METHODS: Aortic vascular smooth muscle cells (VSMC) from 12-week-old SHR and Wistar-Kyoto (WKY) rats were used for the present studies. The levels of inhibitory guanine nucleotide regulatory proteins (Gialpha-2 and Gialpha-3) and stimulatory proteins (Gsalpha) were determined by western blotting techniques. Adenylyl cyclase activity was determined by measuring [32P]cAMP formation from [alpha-32P]ATP.
RESULTS: VSMC from SHR exhibited enhanced expression of Gialpha-2 and Gialpha-3 proteins as compared with age-matched WKY rats; however, the levels of Gsalpha proteins were not different between the two groups. The levels of superoxide anion (O2-) were also increased in SHR as compared with WKY rats, and losartan, an AT1 receptor antagonist, restored the enhanced levels to control WKY rat levels. Treatment of VSMC with antioxidants such as N-acetyl-L-cysteine (NAC) or diphenyleneiodonium (DPI) for 24 h decreased the enhanced expression of Gialpha-2 and Gialpha-3 proteins in a concentration-dependent manner in VSMC from SHR. In addition, the inhibition of forskolin-stimulated enzyme activity by low concentrations of GTPgammaS (receptor-independent Gi functions) and C-ANP4-23-mediated inhibition of adenylyl cyclase (receptor-dependent Gi functions) that were significantly enhanced in SHR were restored to WKY rat levels by NAC and DPI treatments. Similarly, diminished stimulation of adenylyl cyclase by GTPgammaS, isoproterenol and sodium fluoride in SHR was also restored towards control WKY rat levels by NAC and DPI treatments. Furthermore, PD98059, a selective inhibitor of mitogen-activated protein kinase, was able to restore the enhanced expression of Gialpha proteins in VSMC from SHR towards WKY rat levels. In addition, the enhanced activity of extracellular signal-regulated kinase 1/2 in SHR as compared with WKY rats, as demonstrated by enhanced phosphorylation of extracellular signal-regulated kinase 1/2, was also restored to WKY rat levels by NAC or DPI.
CONCLUSIONS: These results suggest that enhanced levels of Gialpha proteins and associated functions in SHR may be attributed to the enhanced oxidative stress present in SHR, which exerts its effects through the mitogen-activated protein kinase signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269967     DOI: 10.1097/01.hjh.0000191905.26853.f1

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

1.  Impaired 3',5'-cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene X-1-deficient vascular smooth muscle cells.

Authors:  Mohd Shahid; Li Shen; David C Seldin; Bao Lu; Irina V Ustyugova; Xinyuan Chen; Warren M Zapol; Mei X Wu
Journal:  Hypertension       Date:  2010-08-16       Impact factor: 10.190

2.  Modulation of Gi Proteins in Hypertension: Role of Angiotensin II and Oxidative Stress.

Authors:  Madhu B Anand-Srivastava
Journal:  Curr Cardiol Rev       Date:  2010-11

Review 3.  Inhibition of adenylyl cyclase type 5 increases longevity and healthful aging through oxidative stress protection.

Authors:  Stephen F Vatner; Ronald E Pachon; Dorothy E Vatner
Journal:  Oxid Med Cell Longev       Date:  2015-04-07       Impact factor: 6.543

4.  Natriuretic peptide receptor-C agonist attenuates the expression of cell cycle proteins and proliferation of vascular smooth muscle cells from spontaneously hypertensive rats: role of Gi proteins and MAPkinase/PI3kinase signaling.

Authors:  Jasmine El Andalousi; Yuan Li; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

5.  Increase or decrease hydrogen sulfide exert opposite lipolysis, but reduce global insulin resistance in high fatty diet induced obese mice.

Authors:  Bin Geng; Bo Cai; Feng Liao; Yang Zheng; Qiang Zeng; Xiaofang Fan; Yongsheng Gong; Jichun Yang; Qing Hua Cui; Chaoshu Tang; Guo Heng Xu
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

6.  Knockdown of Inhibitory Guanine Nucleotide Binding Protein Giα-2 by Antisense Oligodeoxynucleotides Attenuates the Development of Hypertension and Tachycardia in Spontaneously Hypertensive Rats.

Authors:  Yousra Ali El-Basyuni; Yuan Li; Madhu B Anand-Srivastava
Journal:  J Am Heart Assoc       Date:  2016-10-26       Impact factor: 5.501

7.  Contribution of oxidative stress and growth factor receptor transactivation in natriuretic peptide receptor C-mediated attenuation of hyperproliferation of vascular smooth muscle cells from SHR.

Authors:  Sofiane Rahali; Yuan Li; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

8.  Nitric oxide attenuates overexpression of Giα proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling.

Authors:  Oli Sarkar; Yuan Li; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

9.  Inhibition of overexpression of Giα proteins and nitroxidative stress contribute to sodium nitroprusside-induced attenuation of high blood pressure in SHR.

Authors:  Ekhtear Hossain; Oli Sarkar; Yuan Li; Madhu B Anand-Srivastava
Journal:  Physiol Rep       Date:  2018-03

10.  Natriuretic peptide receptor-C-mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqα/PLCβ1 proteins and ROS-associated signaling.

Authors:  Ashish Jain; Madhu B Anand-Srivastava
Journal:  Pharmacol Res Perspect       Date:  2018-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.